• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤中的DNA甲基化亚组与增殖和免疫过程相关。

DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.

作者信息

Lauss Martin, Ringnér Markus, Karlsson Anna, Harbst Katja, Busch Christian, Geisler Jürgen, Lønning Per Eystein, Staaf Johan, Jönsson Göran

机构信息

Department of Oncology and Pathology, Clinical Sciences, Lund University Hospital, Lund University, Lund, 221 85, Sweden.

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.

出版信息

BMC Med Genomics. 2015 Nov 6;8:73. doi: 10.1186/s12920-015-0147-4.

DOI:10.1186/s12920-015-0147-4
PMID:26545983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4636848/
Abstract

BACKGROUND

DNA methylation at CpG dinucleotides is modified in tumorigenesis with potential impact on transcriptional activity.

METHODS

We used the Illumina 450 K platform to evaluate DNA methylation patterns of 50 metastatic melanoma tumors, with matched gene expression data.

RESULTS

We identified three different methylation groups and validated the groups in independent data from The Cancer Genome Atlas. One group displayed hypermethylation of a developmental promoter set, genome-wide demethylation, increased proliferation and activity of the SWI/SNF complex. A second group had a methylation pattern resembling stromal and leukocyte cells, over-expressed an immune signature and had improved survival rates in metastatic tumors (p < 0.05). A third group had intermediate methylation levels and expressed both proliferative and immune signatures. The methylation groups corresponded to some degree with previously identified gene expression phenotypes.

CONCLUSIONS

Melanoma consists of divergent methylation groups that are distinguished by promoter methylation, proliferation and content of immunological cells.

摘要

背景

在肿瘤发生过程中,CpG二核苷酸处的DNA甲基化会发生改变,这可能对转录活性产生影响。

方法

我们使用Illumina 450K平台评估了50例转移性黑色素瘤肿瘤的DNA甲基化模式,并匹配了基因表达数据。

结果

我们识别出三个不同的甲基化组,并在来自癌症基因组图谱的独立数据中验证了这些组。一组表现出发育启动子集的高甲基化、全基因组去甲基化、SWI/SNF复合物增殖和活性增加。第二组的甲基化模式类似于基质细胞和白细胞,过度表达免疫特征,转移性肿瘤的生存率提高(p<0.05)。第三组具有中等甲基化水平,同时表达增殖和免疫特征。甲基化组在一定程度上与先前确定的基因表达表型相对应。

结论

黑色素瘤由不同的甲基化组组成,这些组通过启动子甲基化、增殖和免疫细胞含量来区分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc8/4636848/bf002ffa243e/12920_2015_147_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc8/4636848/d83b39a431b0/12920_2015_147_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc8/4636848/0c10a7e2454a/12920_2015_147_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc8/4636848/fef6ea44d0bb/12920_2015_147_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc8/4636848/bf002ffa243e/12920_2015_147_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc8/4636848/d83b39a431b0/12920_2015_147_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc8/4636848/0c10a7e2454a/12920_2015_147_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc8/4636848/fef6ea44d0bb/12920_2015_147_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc8/4636848/bf002ffa243e/12920_2015_147_Fig4_HTML.jpg

相似文献

1
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.黑色素瘤中的DNA甲基化亚组与增殖和免疫过程相关。
BMC Med Genomics. 2015 Nov 6;8:73. doi: 10.1186/s12920-015-0147-4.
2
Integrative genomics identifies gene signature associated with melanoma ulceration.整合基因组学确定与黑色素瘤溃疡相关的基因特征。
PLoS One. 2013;8(1):e54958. doi: 10.1371/journal.pone.0054958. Epub 2013 Jan 30.
3
Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.通过启动子甲基化基因谱分析鉴定人类黑色素瘤中新型表观遗传修饰基因
Pigment Cell Melanoma Res. 2008 Oct;21(5):545-58. doi: 10.1111/j.1755-148X.2008.00484.x. Epub 2007 Jun 28.
4
Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.黑色素瘤进展至脑转移的全基因组DNA甲基化图谱揭示了与预后相关的同源框D簇异常。
Hum Mol Genet. 2014 Jan 1;23(1):226-38. doi: 10.1093/hmg/ddt420. Epub 2013 Sep 6.
5
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.一项针对肺癌启动子甲基化的全基因组筛查鉴定出多种恶性肿瘤的新型甲基化标志物。
PLoS Med. 2006 Dec;3(12):e486. doi: 10.1371/journal.pmed.0030486.
6
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.甲基化依赖性SOX9表达介导人黑色素瘤细胞的侵袭,并且是晚期黑色素瘤的不良预后因素。
Genome Biol. 2015 Feb 22;16(1):42. doi: 10.1186/s13059-015-0594-4.
7
Methylation of CpG island promoters in uveal melanoma.葡萄膜黑色素瘤中CpG岛启动子的甲基化
Br J Ophthalmol. 2008 Feb;92(2):281-5. doi: 10.1136/bjo.2007.127035. Epub 2008 Jan 22.
8
Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor.胃肠道间质瘤中联合 DNA 甲基化和基因表达谱分析显示 SPP1 的低甲基化是一个独立的预后因素。
Int J Cancer. 2015 Mar 1;136(5):1013-23. doi: 10.1002/ijc.29088. Epub 2014 Aug 1.
9
DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.黑色素瘤风险基因的DNA甲基化水平与黑色素瘤患者的临床特征相关。
Biomed Res Int. 2015;2015:376423. doi: 10.1155/2015/376423. Epub 2015 Apr 12.
10
Promoter methylation status of multiple genes in uveal melanoma.葡萄膜黑色素瘤中多个基因的启动子甲基化状态
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4403-6. doi: 10.1167/iovs.07-0272.

引用本文的文献

1
Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma.综合多组学分析揭示了DNA甲基化图谱在塑造转移性黑色素瘤的生物学异质性和临床行为中的作用。
J Exp Clin Cancer Res. 2025 Jul 18;44(1):212. doi: 10.1186/s13046-025-03474-9.
2
Targeted demethylation of the EphA7 promoter inhibits tumorigenesis via the SP1/DNMT1 and PI3K/AKT axes and improves the response to multiple therapies in cervical cancer.EphA7启动子的靶向去甲基化通过SP1/DNMT1和PI3K/AKT轴抑制肿瘤发生,并改善宫颈癌对多种疗法的反应。
Cell Death Dis. 2025 Apr 21;16(1):324. doi: 10.1038/s41419-025-07512-4.
3

本文引用的文献

1
Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.利用基因表达谱对转移性黑色素瘤进行分子分层:生存结果预测及分子靶向治疗获益情况
Oncotarget. 2015 May 20;6(14):12297-309. doi: 10.18632/oncotarget.3655.
2
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.全基因组 DNA 甲基化分析揭示了 CpG 甲基化在 MITF 调控中的重要性。
J Invest Dermatol. 2015 Jul;135(7):1820-1828. doi: 10.1038/jid.2015.61. Epub 2015 Feb 23.
3
Integrative analysis of 111 reference human epigenomes.
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.
Ⅱ期和Ⅲ期原发性黑色素瘤的 DNA 甲基化分类及其临床和预后意义。
JCO Precis Oncol. 2024 Nov;8:e2400375. doi: 10.1200/PO-24-00375. Epub 2024 Nov 7.
4
Epigenetics and Control of Tumor Angiogenesis in Melanoma: An Update with Therapeutic Implications.黑色素瘤中表观遗传学与肿瘤血管生成的调控:具有治疗意义的最新进展
Cancers (Basel). 2024 Aug 14;16(16):2843. doi: 10.3390/cancers16162843.
5
Identification of a CpG-based signature coupled with gene expression as prognostic indicators for melanoma: a preliminary study.基于 CpG 的标志物联合基因表达鉴定作为黑色素瘤的预后指标:初步研究。
Sci Rep. 2024 Mar 4;14(1):5302. doi: 10.1038/s41598-023-50614-2.
6
Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells.表观遗传调控的 PCDHB15 损害转移性黑素瘤细胞的侵袭能力。
Clin Epigenetics. 2022 Nov 28;14(1):156. doi: 10.1186/s13148-022-01364-x.
7
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype.黑素细胞谱系基因的 DNA 启动子超甲基化决定了黑色素瘤的表型。
JCI Insight. 2022 Oct 10;7(19):e156577. doi: 10.1172/jci.insight.156577.
8
Epigenetics Regulates Antitumor Immunity in Melanoma.表观遗传学调控黑色素瘤中的抗肿瘤免疫。
Front Immunol. 2022 May 25;13:868786. doi: 10.3389/fimmu.2022.868786. eCollection 2022.
9
Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.在黑色素瘤进展的细胞模型中进行全基因组启动子甲基化谱分析,揭示了恶性肿瘤和转移的标志物,这些标志物可预测黑色素瘤的生存。
Clin Epigenetics. 2022 May 23;14(1):68. doi: 10.1186/s13148-022-01291-x.
10
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma.癌细胞表型可塑性作为黑色素瘤免疫逃逸的驱动因素
Front Immunol. 2022 Mar 29;13:873116. doi: 10.3389/fimmu.2022.873116. eCollection 2022.
111 个人类参考基因组的综合分析。
Nature. 2015 Feb 19;518(7539):317-30. doi: 10.1038/nature14248.
4
Pan-cancer patterns of DNA methylation.泛癌症 DNA 甲基化模式。
Genome Med. 2014 Aug 30;6(8):66. doi: 10.1186/s13073-014-0066-6. eCollection 2014.
5
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.检查点阻断癌症免疫疗法靶向肿瘤特异性突变抗原。
Nature. 2014 Nov 27;515(7528):577-81. doi: 10.1038/nature13988.
6
PD-1 blockade induces responses by inhibiting adaptive immune resistance.程序性死亡受体1(PD-1)阻断通过抑制适应性免疫抵抗来诱导反应。
Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954.
7
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.癌症患者对抗PD-L1抗体MPDL3280A反应的预测性相关因素。
Nature. 2014 Nov 27;515(7528):563-7. doi: 10.1038/nature14011.
8
Genetic basis for clinical response to CTLA-4 blockade in melanoma.黑色素瘤中CTLA-4阻断临床反应的遗传基础。
N Engl J Med. 2014 Dec 4;371(23):2189-2199. doi: 10.1056/NEJMoa1406498. Epub 2014 Nov 19.
9
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.BRAF 和 MEK 联合抑制与单独 BRAF 抑制治疗黑色素瘤。
N Engl J Med. 2014 Nov 13;371(20):1877-88. doi: 10.1056/NEJMoa1406037. Epub 2014 Sep 29.
10
Vulnerabilities of mutant SWI/SNF complexes in cancer.癌症中突变型 SWI/SNF 复合物的脆弱性。
Cancer Cell. 2014 Sep 8;26(3):309-317. doi: 10.1016/j.ccr.2014.07.018.